# Ferumoxytol-enhanced Imaging and Mapping in neuroAIDS

> **NCT02678767** · PHASE2 · COMPLETED · sponsor: **Beau Nakamoto** · enrollment: 30 (actual)

## Conditions studied

- AIDS Dementia Complex

## Interventions

- **DRUG:** Ferumoxytol

## Key facts

- **NCT ID:** NCT02678767
- **Lead sponsor:** Beau Nakamoto
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2017-09
- **Final completion:** 2017-09
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2017-10-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02678767

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02678767, "Ferumoxytol-enhanced Imaging and Mapping in neuroAIDS". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT02678767. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*